CLINICAL_TRIALS
trial_result
· 2017-01-27
Clinical Trial Update: Corneal Collagen Cross-Linking for Ectasia (CXL) [Phase 3]
Summary
Phase 3 clinical trial update for corneal collagen cross-linking in ectasia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Glaukos Corporation | Conditions: Ectasia | Phase 3 | Status: COMPLETED | Results posted: 2017-01-27